Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer Journal Article
| Authors: | Wahl, A. O.; Rademaker, A.; Kiel, K. D.; Jones, E. L.; Marks, L. B.; Croog, V.; McCormick, B. M.; Hirsch, A.; Karkar, A.; Motwani, S. B.; Tereffe, W.; Yu, T. K.; Sher, D.; Silverstein, J.; Kachnic, L. A.; Kesslering, C.; Freedman, G. M.; Small, W. Jr |
| Article Title: | Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer |
| Abstract: | Purpose: To review the toxicity and clinical outcomes for patients who underwent repeat chest wall or breast irradiation (RT) after local recurrence. Methods and Materials: Between 1993 and 2005, 81 patients underwent repeat RT of the breast or chest wall for locally recurrent breast cancer at eight institutions. The median dose of the first course of RT was 60 Gy and was 48 Gy for the second course. The median total radiation dose was 106 Gy (range, 74.4-137.5 Gy). At the second RT course, 20% received twice-daily RT, 54% were treated with concurrent hyperthermia, and 54% received concurrent chemotherapy. Results: The median follow-up from the second RT course was 12 months (range, 1-144 months). Four patients developed late Grade 3 or 4 toxicity. However, 25 patients had follow-up >20 months, and no late Grade 3 or 4 toxicities were noted. No treatment-related deaths occurred. The development of Grade 3 or 4 late toxicity was not associated with any repeat RT variables. The overall complete response rate was 57%. No repeat RT parameters were associated with an improved complete response rate, although a trend was noted for an improved complete response with the addition of hyperthermia that was close to reaching statistical significance (67% vs. 39%, p = 0.08). The 1-year local disease-free survival rate for patients with gross disease was 53% compared with 100% for those without gross disease (p < 0.0001). Conclusions: The results of our study have shown that repeat RT of the chest wall for patients with locally recurrent breast cancer is feasible, because it is associated with acceptable acute and late morbidity and encouraging local response rates. © 2008 Elsevier Inc. All rights reserved. |
| Keywords: | cancer chemotherapy; cancer survival; treatment response; disease-free survival; fracture; antineoplastic agents; cancer radiotherapy; disease free survival; radiation dose; combined modality therapy; chemotherapy; recurrent cancer; follow up; follow-up studies; antineoplastic agent; neoplasm recurrence, local; breast cancer; radiotherapy dosage; radiotherapy; breast neoplasms; cancer therapy; pneumonia; fibrosis; statistical significance; tumors; burn; irradiation; radiation injuries; dermatitis; hyperthermia; hyperthermia, induced; toxicity; thorax wall; thoracic wall; bone necrosis; retreatment; diseases; lung infiltrate; skin infection; pericarditis; repeat procedure; local recurrence; institutional care; arm edema; repeat irradiation; hyperthermia therapy |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 70 |
| Issue: | 2 |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2008-02-01 |
| Start Page: | 477 |
| End Page: | 484 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2007.06.035 |
| PUBMED: | 17869019 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 8" - "Export Date: 17 November 2011" - "CODEN: IOBPD" - "Source: Scopus" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work